Our paper in ASM discusses a new assay developed by MMV, Swiss TPH and Universität Hamburg that will enable better selection of potential drug combinations and aid in predicting more accurate drug dosage.

Read: bit.ly/3f5JkHZ

If you're at ICTMM2020 Bangkok, I invite you to attend my Medicines for Malaria Venture (MMV) colleagues' presentations:

Jeremy Burrows will speak on Tues about antimalarial innovation.

On Wed, Stephan Duparc will participate in a panel on post-registration studies in antimalarial development.

With little access to flooded district hospitals or even the traditional village dais (midwives) that they might usually turn to, expectant mothers are struggling in the displaced-person camps of flood-hit Pakistan. vogue.cm/3lVboDP

We're excited to be at ICTMM2020 Bangkok! We'll be talking about our work on strengthening mobile health 📱 to improve disease surveillance in #Mozambique and lessons learnt training malaria volunteers to deliver integrated community case management in Myanmar #ICTMM2022

🗓️Save the date!

If you're attending #TropMed22 , you are cordially invited to lunches hosted by the SMC Alliance to discuss:

⮕ optimizing national seasonal malaria chemoprevention campaigns
⮕ SMC advocacy and communications strategies

Details 👇

For this episode of the #GlobalHealthMatters 🎙️podcast, we’ve partnered with #GISRS to learn more about how this global network has protected the world against influenza for 70 years.

Hear more as Dr Garry Aslanyan speaks to John McCauley & Mahmudur Rahman👉bit.ly/3D7NOH6

The RBM Partnership is delighted to announce the appointment of Noella Umulisa as co-chair of our Case Management Working Group (CMWG), alongside Dr Larry Barat! We also thank our departing co-chair, Dr Juma, for working tirelessly to keep country teams at the heart of our work.

This #WorldCitiesDay , join World Health Organization (WHO) and UN-Habitat for the official launch of the 'Global framework for the response to malaria in urban areas'!

📅 Monday 31 October
⏰15:00 – 16:30 CET / 9:00 – 10:30 EST
Register for the webinar ⬇️
who.int/news-room/even…

#FakeMedicines pose a serious threat to disease elimination efforts and lead to increased mortality rates. It is important to keep track of pharmaceutical products in circulation to ensure compliance to quality and to avert a repetation of the situation in the Gambia.

The World Health Summit brought together global health actors to discuss how to achieve #healthforall . Health for all must include pregnant women's #malaria prevention and treatment needs.

Read Medicines for Malaria Venture (MMV)’s op-ed in GHTC to learn more: bit.ly/3rZKVSv

This World Health Summit, Medicines for Malaria Venture (MMV) are reflecting on how the partnership advocates for and advances innovative research approaches to improve the availability of well-tolerated and effective antimalarials for pregnant individuals. bit.ly/3rTVXbU

With funding from Unitaid, Medicines for Malaria Venture (MMV) aims to support the implementation of Perennial Malaria Chemoprevention using Sulfadoxine Pyrimethamine by developing a pediatric formulation and making it easier for providers to give children the correct dose.

Read the statement by Adam Aspinall, MMV Senior Director of Access and Product Management and Chair of Fight the Fakes Alliance on the contaminated drugs that tragically claimed the lives of at least 66 children in the Gambia (below).

I took some time to reflect on a recent session I moderated at #UNGA77 #ScienceSummit in my latest blog. As outbreaks of infectious disease surge, are we
Turning The Page Too Soon? Will we learn lessons to better prepare?
Drugs for Neglected Diseases initiative Medicines for Malaria Venture (MMV) TB Alliance theiddoc.net/2022/10/14/ung…

Our latest newsletter is packed full of IVCC updates, blogs and publications, as well as news and events from our partners working on #malaria and #vectorcontrol . Read it now, and sign up if you haven't already!

createsend.com/t/t-B8DBB0056E…

Interesting to hear Medicines for Malaria Venture (MMV) Andrea Lucard's pitch to Science and Technology Committee for consideration of an inquiry into product development pipeline policy relating to malaria interventions IVCC Malaria No More UK 👇 bit.ly/3MPtJZG

During this year's World Health Summit, Medicines for Malaria Venture (MMV) is using the opportunity to draw attention to the fact that pregnant individuals are underserved by currently available #antimalarial therapies.

Today Andrea Lucard of Medicines for Malaria Venture (MMV) is speaking to Science and Technology Committee about the importance of Product Development Partnerships. She's speaking on behalf of IVCC Malaria No More UK